Correlation Between Biodexa Pharmaceticals and Virios Therapeutics

Can any of the company-specific risk be diversified away by investing in both Biodexa Pharmaceticals and Virios Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biodexa Pharmaceticals and Virios Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Biodexa Pharmaceticals and Virios Therapeutics Llc, you can compare the effects of market volatilities on Biodexa Pharmaceticals and Virios Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biodexa Pharmaceticals with a short position of Virios Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biodexa Pharmaceticals and Virios Therapeutics.

Diversification Opportunities for Biodexa Pharmaceticals and Virios Therapeutics

0.63

Correlation Coefficient

Biodexa Pharmaceticals  Virios Therapeutics

Poor diversification

The 3 months correlation between Biodexa and Virios is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Biodexa Pharmaceticals and Virios Therapeutics Llc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Virios Therapeutics Llc and Biodexa Pharmaceticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biodexa Pharmaceticals are associated (or correlated) with Virios Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Virios Therapeutics Llc has no effect on the direction of Biodexa Pharmaceticals i.e., Biodexa Pharmaceticals and Virios Therapeutics go up and down completely randomly.

Pair Corralation between Biodexa Pharmaceticals and Virios Therapeutics

Given the investment horizon of 90 days Biodexa Pharmaceticals is expected to under-perform the Virios Therapeutics. In addition to that, Biodexa Pharmaceticals is 1.33 times more volatile than Virios Therapeutics Llc. It trades about -0.06 of its total potential returns per unit of risk. Virios Therapeutics Llc is currently generating about 0.03 per unit of volatility. If you would invest  622.00  in Virios Therapeutics Llc on September 12, 2024 and sell it today you would lose (227.00) from holding Virios Therapeutics Llc or give up 36.5% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	92.93%
Values	Daily Returns

Biodexa Pharmaceticals  vs.  Virios Therapeutics Llc

Biodexa Pharmaceticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Biodexa Pharmaceticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Virios Therapeutics Llc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Virios Therapeutics Llc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Virios Therapeutics is not utilizing all of its potentials. The newest stock price confusion, may contribute to short-horizon losses for the traders.

Pair Trading with Biodexa Pharmaceticals and Virios Therapeutics

The main advantage of trading using opposite Biodexa Pharmaceticals and Virios Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biodexa Pharmaceticals position performs unexpectedly, Virios Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virios Therapeutics will offset losses from the drop in Virios Therapeutics' long position.

The idea behind Biodexa Pharmaceticals and Virios Therapeutics Llc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.